Chronic asthma and Mesenchymal stem cells: Hyaluronan and airway remodeling

Background: previous studies have demonstrated that ovalbumin sensitization promotes chronic asthma phenotype in murine asthma model. human mesenchymal stem cells (hmscs) are multipotent cells in vitro that have been shown to decrease inflammation and can reverse airway remodeling when infused into an in vivo chronic asthma model. however,the mechanism by which hmscs reverse remodeling is still unclear. in this study,we hypothesized that hmscs influence remodeling by decreasing extracellular matrix (ecm) deposition,more specifically by decreasing collagen i,collagen iii,and hyaluronan synthesis. methods: chronic asthma phenotype was produced in an in vitro model with 3 t3 murine airway fibroblast cells by stimulating with gm-csf. collagen i and collagen iii gene expression was investigated using rt-pcr and taqman techniques. hyaluronan was evaluated using face and western blots. the chronic asthma phenotype was produced in vivo in murine model using sensitization with ovalbumin with and without hmsc infusion therapy. ecm deposition (specifically trichrome staining,soluble and insoluble collagen deposition,and hyaluronan production) was evaluated. image quantification was used to monitor trichrome staining changes. results: gm-csf which induced collagen i and collagen iii production was down-regulated with hmsc using co-culture. in the in vivo model,ovalbumin induced enhanced ecm deposition,soluble and insoluble collagen production,and lung elastance. hmsc infusions decreased ecm deposition as evidenced by decreases in soluble and insoluble collagen production. conclusion: hmscs participate in improved outcomes of remodeling by reversing excess collagen deposition and changing hyaluronan levels. © 2017 the author(s).